Utilization of membrane vesicle preparations to study drug–ABC transporter interactions

Bibliography

• Glavinas H, Krajcsi P, Cserepes J, et al. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 2004;1:27-42
   PubMedGoogle Scholar
• Sarkadi B, Homolya L, Szakacs G, et al. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 2006;86:1179-236
   PubMed Web of Science ®Google Scholar
• Mizuno N, Niwa T, Yotsumoto Y, et al. Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 2003;55:425-61
   PubMed Web of Science ®Google Scholar
• Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 2003;42(1):59-98
   PubMed Web of Science ®Google Scholar
• Martonosi A, Feretos R. Sarcoplasmic reticulum. I. The uptake of Ca++ by sarcoplasmic reticulum fragments. J Biol Chem 1964;239:648-58
   PubMed Web of Science ®Google Scholar
• Steck TL, Weinstein RS, Straus JH, et al. Inside-out red cell membrane vesicles: preparation and purification. Science 1970;168(928):255-7
   PubMed Web of Science ®Google Scholar
• Steck TL, Kant JA. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol 1974;31(Pt A):172-80
   PubMedGoogle Scholar
• Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;455(1):152-62
   PubMed Web of Science ®Google Scholar
• Shen DW, Fojo A, Chin JE, et al. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 1986;232(4750):643-5
   PubMed Web of Science ®Google Scholar
• Chen CJ, Chin JE, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986;47(3):381-9
   PubMed Web of Science ®Google Scholar
• Ueda K, Cornwell MM, Gottesman MM, et al. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 1986;141(3):956-62
   PubMed Web of Science ®Google Scholar
• Horio M, Gottesman MM, Pastan I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci USA 1988;85(10):3580-4
   PubMed Web of Science ®Google Scholar
• Doige CA, Sharom FJ. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. Biochim Biophys Acta 1992;1109(2):161-71
   PubMed Web of Science ®Google Scholar
• Sarkadi B, Price EM, Boucher RC, et al. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 1992;267(7):4854-8
   PubMed Web of Science ®Google Scholar
• Urbatsch IL, Sankaran B, Weber J et al. P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem 1995;270(33):19383-90
   PubMed Web of Science ®Google Scholar
• ABC transporters: biochemical, cellular and molecular aspects. Methods Enzymol (1998) 292
   Google Scholar
• Bakos E, Evers R, Szakacs G, et al. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J Biol Chem 1998;273(48):32167-75
   PubMed Web of Science ®Google Scholar
• Zeng H, Liu G, Rea PA, et al. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res 2000;60(17):4779-84
   PubMed Web of Science ®Google Scholar
• Glavinas H, Kis E, Pal A, et al. ABCG2 (BCRP/MXR) ATPase assay: a useful tool to detect drug-transporter interactions. Drug Metab Dispos 2007
   Google Scholar
• Sharom FJ, Yu X, Lu P, et al. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. Biochem Pharmacol 1999;58(4):571-86
   PubMed Web of Science ®Google Scholar
• Paulusma CC, Bosma PJ, Zaman GJ, et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996;271(5252):1126-8
   PubMed Web of Science ®Google Scholar
• Zelcer N, Huisman MT, Reid G et al. Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). J Biol Chem 2003;278(26):23538-44
   PubMed Web of Science ®Google Scholar
• Bodo A, Bakos E, Szeri F, et al. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J Biol Chem 2003;278(26):23529-37
   PubMed Web of Science ®Google Scholar
• Cui Y, Konig J, Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol 2001;60(5):934-43
   PubMed Web of Science ®Google Scholar
• Sasaki M, Suzuki H, Ito K, et al. Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and multidrug resistance-associated protein 2 (MRP2/ABCC2). J Biol Chem 2002;277(8):6497-503
   PubMed Web of Science ®Google Scholar
• Bartholome K, Rius M, Letschert K, et al. Data-based mathematical modeling of vectorial transport across double-transfected polarized cells. Drug Metab Dispos 2007;35(9):1476-81
   PubMed Web of Science ®Google Scholar
• Stieger B, Fattinger K, Madon J, et al. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 2000;118(2):422-30
   PubMed Web of Science ®Google Scholar
• Stieger B, O'Neill B, Meier PJ. ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles. Biochem J 1992;284(Pt 1):67-74
   PubMed Web of Science ®Google Scholar
• Strautnieks SS, Bull LN, Knisely AS, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998;20(3):233-8
   PubMed Web of Science ®Google Scholar
• Bakos E, Evers R, Sinko E, et al. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol Pharmacol 2000;57(4):760-8
   PubMed Web of Science ®Google Scholar
• Lespine A, Dupuy J, Orlowski S, et al. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem Biol Interact 2006;159(3):169-79
   PubMed Web of Science ®Google Scholar
• Williamson G, Aeberli I, Miguet L, et al. Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2). Drug Metab Dispos 2007;35(8):1262-8
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin G, Kovacs B, et al. Mechanistic study on the intestinal absorption and disposition of baicalein. Eur J Pharm Sci 2007;31(3-4):221-31
   PubMed Web of Science ®Google Scholar
• Currier SJ, Ueda K, Willingham MC, et al. Deletion and insertion mutants of the multidrug transporter. J Biol Chem 1989;264(24):14376-81
   PubMed Web of Science ®Google Scholar
• Broxterman HJ, Pinedo HM, Kuiper CM, et al. Induction by verapamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells. FASEB J 1988;2(7):2278-82
   PubMed Web of Science ®Google Scholar
• Litman T, Nielsen D, Skovsgaard T, et al. ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines. Biochim Biophys Acta 1997;1361(2):147-58
   PubMed Web of Science ®Google Scholar
• Buxbaum E. Co-operative binding sites for transported substrates in the multiple drug resistance transporter Mdr1. Eur J Biochem 1999;265(1):64-70
   PubMedGoogle Scholar
• Al-Shawi MK, Polar MK, Omote H, et al. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein. J Biol Chem 2003;278(52):52629-40
   PubMed Web of Science ®Google Scholar
• Shirasaka Y, Onishi Y, Sakurai A, et al. Evaluation of human P-glycoprotein (MDR1/ABCB1) ATPase activity assay method by comparing with in vitro transport measurements: Michaelis-Menten kinetic analysis to estimate the affinity of P-glycoprotein to drugs. Biol Pharm Bull 2006;29(12):2465-71
   PubMed Web of Science ®Google Scholar
• Goldberg H, Ling V, Wong PY, et al. Reduced cyclosporin accumulation in multidrug-resistant cells. Biochem Biophys Res Commun 1988;152(2):552-8
   PubMed Web of Science ®Google Scholar
• Szabo K, Welker E, Bakos, et al. Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains. J Biol Chem 1998;273(17):10132-8
   PubMed Web of Science ®Google Scholar
• van Helvoort A, Smith AJ, Sprong H, et al. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 1996;87(3):507-17
   PubMed Web of Science ®Google Scholar
• Smith AJ, van Helvoort A, van Meer G, et al. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem 2000;275(31):23530-9
   PubMed Web of Science ®Google Scholar
• Loe DW, Almquist KC, Deeley RG, et al. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. J Biol Chem 1996;271(16):9675-82
   PubMed Web of Science ®Google Scholar
• Volk EL, Schneider E. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res 2003;63(17):5538-43
   PubMed Web of Science ®Google Scholar
• Meier PJ, Sztul ES, Reuben A, et al. Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. J Cell Biol 1984;98(3):991-1000
   PubMed Web of Science ®Google Scholar
• Germann UA, Chambers TC, Ambudkar SV, et al. Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J Biol Chem 1996;271(3):1708-16
   PubMed Web of Science ®Google Scholar
• Pal A, Mehn D, Molnar E, et al. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2. J Pharmacol Exp Ther 2007;321(3):1085-94
   PubMed Web of Science ®Google Scholar
• Kondo T, Dale GL, Beutler E. Simple and rapid purification of inside-out vesicles from human erythrocytes. Biochim Biophys Acta 1980;602(1):127-30
   PubMed Web of Science ®Google Scholar
• Ruetz S, Raymond M, Gros P. Functional expression of P-glycoprotein encoded by the mouse mdr3 gene in yeast cells. Proc Natl Acad Sci USA 1993;90(24):11588-92
   PubMed Web of Science ®Google Scholar
• Boyer JL, Allen RM, Ng OC. Biochemical separation of Na+,K+-ATPase from a “purified” light density, ‘canalicular’-enriched plasma membrane fraction from rat liver. Hepatology 1983;3(1):18-28
   PubMed Web of Science ®Google Scholar
• Meier PJ, St Meier-Abt A, Barrett C, et al. Mechanisms of taurocholate transport in canalicular and basolateral rat liver plasma membrane vesicles. Evidence for an electrogenic canalicular organic anion carrier. J Biol Chem 1984;259(16):10614-22
   PubMedGoogle Scholar
• Gerloff T, Stieger B, Hagenbuch B, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273(16):10046-50
   PubMed Web of Science ®Google Scholar
• Jedlitschky G, Leier I, Buchholz U, et al. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J 1997;327(Pt 1):305-10
   PubMed Web of Science ®Google Scholar
• Slate DL, Bruno NA, Casey SM, et al. RS-33295-198: a novel, potent modulator of P-glycoprotein-mediated multidrug resistance. Anticancer Res 1995;15(3):811-4
   PubMed Web of Science ®Google Scholar
• Allen JD, van Loevezijn A, Lakhai JM, et al. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther 2002;1(6):417-25
   PubMed Web of Science ®Google Scholar
• Telbisz A, Muller M, Ozvegy-Laczka C, et al. Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter. Biochim Biophys Acta 2007;1768(11):2698-713
   PubMed Web of Science ®Google Scholar
• Storch CH, Ehehalt R, Haefeli WE, et al. Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro. J Pharmacol Exp Ther 2007;323(1):257-64
   PubMed Web of Science ®Google Scholar
• Doige CA, Yu X, Sharom FJ. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochim Biophys Acta 1992;1109(2):149-60
   PubMed Web of Science ®Google Scholar
• Ambudkar SV, Lelong IH, Zhang J, et al. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci USA 1992;89(18):8472-6
   PubMed Web of Science ®Google Scholar
• Sharom FJ, Yu X, Doige CA. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J Biol Chem 1993;268(32):24197-202
   PubMed Web of Science ®Google Scholar
• Homolya L, Hollo M, Muller M, et al. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Br J Cancer 1996;73(7):849-55
   PubMed Web of Science ®Google Scholar
• Polli JW, Wring SA, Humphreys JE, et al. Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther 2001;299(2):620-8
   PubMed Web of Science ®Google Scholar
• Rautio J, Humphreys JE, Webster LO, et al. In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Drug Metab Dispos 2006;34(5):786-92
   PubMed Web of Science ®Google Scholar
• Bart J, Willemsen AT, Groen HJ, et al. Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET. Neuroimage 2003;20(3):1775-82
   PubMed Web of Science ®Google Scholar
• Fahey JM, Pritchard GA, Moltke LL, et al. Effects of ketoconazole on triazolam pharmacokinetics, pharmacodynamics and benzodiazepine receptor binding in mice. J Pharmacol Exp Ther 1998;285(1):271-6
   PubMed Web of Science ®Google Scholar
• Xiao Y, Davidson R, Smith A, et al. A 96-well efflux assay to identify ABCG2 substrates using a stably transfected MDCK II cell line. Mol Pharm 2006;3(1):45-54
   PubMed Web of Science ®Google Scholar
• Feng B, Mills J, Davidson R, et al. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system. Drug Metab Dispos 2007
   Google Scholar
• Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 2005;22(1):11-23
   PubMed Web of Science ®Google Scholar
• Noe J, Stieger B, Meier PJ. Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 2002;123(5):1659-66
   PubMed Web of Science ®Google Scholar